Jazz Pharmaceuticals Plc
(NASDAQ) JAZZ
Jazz Pharmaceuticals Plc Financials at a Glance
Market Cap
$14.45B
Revenue (TTM)
$4.44B
Net Income (TTM)
$29.49M
EPS (TTM)
-$0.02
P/E Ratio
-12501.09
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$237.58
Volume
975,206
Open
$231.44
Price
$237.58
Volume
975,206
Open
$231.44
Previous Close
$237.72
Daily Range
$230.25 - $238.23
52-Week Range
$105.00 - $243.32
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$237.58
Volume
975,206
Open
$231.44
Previous Close
$237.72
Daily Range
$230.25 - $238.23
52-Week Range
$105.00 - $243.32
Estimated Earnings Date
Aug 4, 2026
JAZZ News
JAZZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jazz Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,890
CEO
Renée D. Galá, MBA
Website
www.jazzpharma.comHeadquarters
Dublin, D04 E5W7, IE
JAZZ Financials
Key Financial Metrics (TTM)
Gross Margin
84.12%
Operating Margin
11.13%
Net Income Margin
0.66%
Return on Equity
0.71%
Return on Capital
2.30%
Return on Assets
0.25%
Earnings Yield
-0.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.45B
Shares Outstanding
62.82M
Volume
975.21K
Avg. Volume
931.89K
Financials (TTM)
Gross Profit
$3.73B
Operating Income
$494.11M
EBITDA
$544.13M
Operating Cash Flow
$1.33B
Capital Expenditure
-$88.57M
Free Cash Flow
$1.25B
Cash & ST Invst.
$2.87B
Total Debt
$5.42B
Jazz Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.07B
+19.1%
Gross Profit
$762.50M
-3.9%
Gross Margin
71.34%
N/A
Market Cap
$14.45B
N/A
Market Cap/Employee
$5.00M
N/A
Employees
2,890
N/A
Net Income
$293.10M
+416.7%
EBITDA
$543.90M
+291.7%
Quarterly Fundamentals
Total Cash
$2.87B
+11.8%
Total Debt
$5.42B
-0.1%
Accounts Receivable
$836.30M
+28.1%
Inventory
$437.50M
-11.2%
Long Term Debt
$4.37B
-18.7%
Short Term Debt
$1.05B
+2252.2%
Return on Assets
0.25%
N/A
Return on Invested Capital
5.14%
N/A
Free Cash Flow
$388.50M
-0.6%
Operating Cash Flow
$408.20M
-5.0%